GHK

GHK is the naturally occurring tripeptide glycyl-L-histidyl-L-lysine. Researchers first became interested in its effects on cultured liver cells and subsequently linked those effects to its ability to bind copper. Later work explored repair-associated gene expression and the behavior of human lung fibroblasts. This chemistry makes GHK a useful example of how the substance added to an experiment can interact with its surroundings before a biological response is measured.

Overview

Molecular profile

Form: Free glycyl-L-histidyl-L-lysine (GHK/prezatide) Source
Sequence: H-Gly-L-His-L-Lys-OH (GHK) Source
Length: 3 amino acids Source
Molecular formula: C14H24N6O4 (free peptide) Source
Molecular weight: Approximately 340.4 g/mol (free peptide) Source
PubChem record: CID 73587, stereochemically defined L-histidine/L-lysine peptide Source

Forms and derivatives

GHK-Cu

Copper-associated GHK. Solution conditions and competing ligands determine the species present; deliberately prepared copper-complex studies are discussed on the GHK-Cu profile.

GHK acetate

An acetate-containing salt preparation. The free-peptide formula above excludes its counterion.

Palmitoylated GHK

A lipid-modified GHK derivative used in cosmetic-formulation research. The 2016 nanocarrier report discusses this derivative and includes a commercial multipeptide comparator.

The name GHK records the amino-acid sequence: glycine, histidine and lysine. The free peptide has formula C14H24N6O4 and a molecular weight of approximately 340.38 g/mol in the stereochemically defined PubChem record. Copper is absent from that molecular formula. GHK-Cu describes the peptide associated with copper, while acetate and palmitoylated preparations introduce other chemical features that should be specified separately. PubChem CID 73587

GHK's identity as a free peptide describes the starting material. Once added to blood, tissue fluid or culture medium, it can bind available metal ions. Consequently, a study that introduces GHK can contain both unbound peptide and metal-associated species during the experiment. The original copper-binding work makes this distinction central to interpreting GHK research. Pickart et al., Lau and Sarkar

Uses and research areas

The main experimental areas represented here are cell survival and growth, copper handling, and tissue-remodeling behavior. Early liver-cell studies asked whether a plasma-associated tripeptide could change the survival of differentiated cells. The copper studies then investigated a possible explanation for its varied effects across cultured systems. More recent lung work asked whether GHK could change an expression pattern associated with emphysema and restore an impaired fibroblast behavior.

These are useful research questions because tissue repair requires cells to remain viable, interact with their matrix and respond to local chemical conditions. Their outcomes also require careful interpretation. Growth in a tumor-cell line, altered gene expression and contraction of a laboratory collagen gel measure different processes; each must be connected to a particular clinical outcome before it can support a therapeutic claim. Pickart, Thayer and Thaler, Campbell et al.

Mechanism of action

A small peptide with consequential metal chemistry

The histidine residue contains an imidazole ring whose atoms can participate in copper coordination. Other groups on the peptide also contribute to binding. Lau and Sarkar studied GHK with copper across different chemical conditions, with and without additional histidine. They found multiple species in solution and complexes involving both peptide and histidine. They also demonstrated competition with albumin, the major blood protein, for copper in an equilibrium-binding experiment. Lau and Sarkar

This dynamic chemistry can change which form reaches a cell and how copper is made available. Pickart and colleagues reported that GHK readily formed copper(II) complexes and enhanced copper uptake by cultured hepatoma cells. Their broader observations included varied growth and differentiation responses, and toxicity in some cultured systems. The results support a copper-handling hypothesis while showing that biological activity depends on the experimental setting. Pickart et al.

Connecting expression changes to a measured cell behavior

The emphysema work developed a different mechanistic connection. Researchers identified gene-expression changes associated with more severe destruction in lung tissue, then used a database of compound-induced expression patterns to identify candidates that might reverse that pattern. GHK was one such candidate. Follow-up experiments examined human lung fibroblasts, cells that interact with the surrounding matrix. GHK treatment altered expression and was associated with reorganization of actin and increased integrin-β1, a protein involved in cell attachment. The cells also regained the ability to contract collagen gels. Campbell et al.

The expression data and gel experiment strengthen one another by linking a molecular pattern to a functional culture readout. They still leave the larger tissue question open: useful lung repair would require restoration of organized architecture and gas exchange without excessive scarring.

Pharmacokinetics

The acquired free-GHK studies do not provide a validated human concentration-time profile or an exact human elimination half-life suitable for a graph. Copper coordination, enzymatic peptide breakdown and tissue distribution are distinct processes, and an assay must specify whether it measures unbound peptide, a complex, total peptide or copper itself.

This distinction also affects topical research. A skin-diffusion study of a copper preparation quantified copper in tissue and receptor fluid, while formulation work has sometimes quantified GHK after preparing GHK-Cu. Those measurements are informative for their particular analytes; they cannot supply free-GHK plasma kinetics. The GHK-Cu profile discusses the copper penetration experiment in its actual formulation and measurement context. Hostynek, Dreher and Maibach, Badenhorst, Svirskis and Wu

Research findings

The original liver-cell experiment

In 1973, Pickart, Thayer and Thaler tested synthetic glycyl-histidyl-lysine in cultures containing normal hepatocytes from regenerating rat liver and a hepatoma-cell line. GHK prolonged survival of the normal cells and enhanced growth of the tumor-cell line. It also increased incorporation of labeled nucleic-acid precursors into cellular material. Pickart, Thayer and Thaler

The findings established biological activity under culture conditions. The hepatoma response also shows why growth stimulation needs its cellular context: an effect that supports normal-cell survival can have a different implication in a tumor line. The accessed abstract does not establish that metals were excluded from the medium, so it cannot isolate a permanently copper-free mechanism.

Copper uptake and competing ligands

The 1980 Nature paper connected GHK with copper uptake in cultured hepatoma cells. Its structure-function reasoning drew on metal association and related peptides, helping explain how a short peptide could produce diverse responses. The subsequent equilibrium study demonstrated several GHK-copper species and competition with albumin. Together these papers establish that metal association is a measurable property of GHK and a relevant contributor to biological interpretation. Pickart et al., Lau and Sarkar

Neither design determines how much of a clinical response would come from peptide, metal or complex. That question calls for appropriately matched comparisons within the same biological model.

Emphysema tissue and cultured fibroblasts

Campbell and colleagues examined 64 regional tissue specimens from eight lungs: six removed during transplantation for severe COPD and two unused donor lungs. The repeated regions allowed investigators to compare areas with different degrees of destruction within the same lung. They were repeated tissue measurements from eight donors, which matters for the statistical interpretation. Campbell et al.

The researchers then performed compound matching and cell experiments. The fibroblast cultures came from former smokers with normal lung function or severe COPD; their acquisition is described separately from the regional tissue series. GHK changed repair-associated gene expression and restored contraction in COPD-derived fibroblasts embedded in collagen gels. The tissue donors and cell donors provided research material. Patients received no GHK treatment in this study, and clinical lung function was not an intervention outcome. Campbell et al.

Safety and tolerability

The studies of GHK reviewed here are predominantly chemical and cellular. These studies cannot provide rates of adverse events in people, define long-term exposure limits or establish a safety profile for systemic administration. GHK's natural occurrence also leaves those questions open, because introducing additional material changes exposure and may change its chemical associations.

The liver-cell and copper-uptake papers require particular care when discussing cancer. Stimulation of hepatoma growth in culture is an experimental observation, and the Nature paper describes toxicity in some culture settings. These results support studying cell type and metal environment as determinants of response. They do not establish that GHK causes cancer, prevents it or treats it in people. Pickart, Thayer and Thaler, Pickart et al.

No approved therapeutic indication or adequate free-GHK clinical benefit-and-harm assessment was identified in this source review. Clinical and cosmetic findings from deliberately prepared GHK-Cu belong with that preparation, including FDA's route-specific concerns about compounded injectable GHK-Cu. FDA compounding context

What the research means

GHK research is strongest as an account of metal-binding chemistry and measurable cellular responses. The emphysema study adds a useful progression from tissue observations to compound screening and functional cell experiments. It identifies a candidate repair-related response without establishing clinical regeneration.

The key uncertainty is the connection between those model outcomes and benefit in living tissue. A clinical study would need to define the preparation, demonstrate relevant exposure, choose a meaningful functional endpoint and track harms. Chemical controls would also help determine how free peptide and copper-associated species contribute. Keeping these questions visible makes the evidence intelligible while preserving the findings that led investigators to pursue GHK.

FAQs

Can GHK remain copper-free in an experiment?

GHK can bind copper already present in serum or culture medium, so a preparation that starts as free GHK may contain copper-bound forms during the experiment. To separate their contributions, researchers need comparisons that control the copper available to the cells as well as the amount of peptide.

Were COPD patients treated with GHK in the emphysema paper?

Patients donated tissue used for observations and cell cultures. The GHK intervention took place in laboratory fibroblasts. Clinical lung function, symptoms and patient harms were not treatment outcomes.

What does collagen-gel contraction show?

It shows that fibroblasts can attach to and exert force on a collagen matrix in culture. This is a useful remodeling behavior. Restoration of lung architecture and gas exchange would require additional tissue and clinical measurements.

Does GHK's occurrence in the body establish safety?

Natural occurrence describes its origin. Additional exposure, route and formulation can change the amounts and chemical species encountered by tissues. The acquired free-GHK studies do not supply a long-term clinical safety assessment.

Do the hepatoma findings mean that GHK causes or treats cancer?

The early study measured enhanced growth in a cultured hepatoma line alongside survival of normal rat liver cells. That observation makes cell type important when interpreting growth effects. It cannot determine cancer risk or treatment benefit in people.

References

Pickart L, Thayer L, Thaler MM. A synthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells. Biochemical and biophysical research communications. 1973;54(2):562–566. DOI: 10.1016/0006-291x(73)91459-9.
Synthetic GHK prolonged survival of normal rat hepatocytes and enhanced hepatoma-cell growth in culture.
Pickart L, Freedman JH, Loker WJ, Peisach J, Perkins CM, Stenkamp RE, Weinstein B. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288(5792):715–717. DOI: 10.1038/288715a0.
GHK formed copper(II) complexes and increased copper uptake in cultured hepatoma cells, with diverse responses across culture systems.
Campbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, Suzuki M, Gosselink JV, Liu G, Alekseyev YO, Xiao J, Zhang X, Hayashi S, Cooper JD, Timens W, Postma DS, Knight DA, Lenburg ME, Hogg JC, Spira A. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome medicine. 2012;4(8):67. DOI: 10.1186/gm367.
Researchers compared gene activity in lung regions with different degrees of emphysema, then tested GHK in separately obtained lung fibroblasts. Treated COPD-derived cells regained the ability to pull on and contract collagen gels. Patients were not treated with GHK.
Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. The Biochemical journal. 1981;199(3):649–656. DOI: 10.1042/bj1990649.
Chemical equilibrium experiments found multiple copper-GHK species and competition with albumin for copper.
National Center for Biotechnology Information. PubChem Compound Summary, CID 73587: glycyl-L-histidyl-L-lysine (prezatide). Accessed October 13, 2026.
Stereochemically defined free-GHK identity record; depositor synonyms are not evidence that free peptide and copper complex are interchangeable.
Hostynek JJ, Dreher F, Maibach HI. Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy. Inflammation Research. 2010;59(11):983–988. DOI: 10.1007/s00011-010-0214-4.
The final skin-diffusion publication measured copper after applying a cuprate-diacetate preparation, providing a transport observation for copper in excised tissue.
Hostynek JJ, Dreher F, Maibach HI. Erratum to: Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflammation Research. 2011;60(6):611. DOI: 10.1007/s00011-011-0343-4.
Identifies the 2011 paper as a duplicate preliminary version and directs readers to the revised final 2010 publication.
Badenhorst T, Svirskis D, Wu Z. Physicochemical characterization of native glycyl-L-histidyl-L-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery. Pharmaceutical Development and Technology. 2016;21(2):152–160. DOI: 10.3109/10837450.2014.979944. Published online November 11, 2014.
Despite the abbreviated peptide wording in the title, the abstract identifies GHK-Cu as the tested preparation and describes GHK quantification during formulation studies.
U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Current agency web record, accessed October 13, 2026.
Agency safety context distinguishes injectable GHK-Cu and the thymosin β4 fragment from other preparations.
Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z. Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. Journal of Aging Science. 2016;4(3):166. DOI: 10.4172/2329-8847.1000166.
The introduction discusses lipid-modified GHK; the clinical comparison concerns a GHK-Cu nanocarrier formula and a commercial multipeptide serum.
Pickart L, Thayer L, Thaler MM. A synthetic tripeptide which increases survival of normal liver cells, and stimulates growth in hepatoma cells. Biochemical and Biophysical Research Communications. 1973;54(2):562–566. DOI: 10.1016/0006-291X(73)91459-9. PubMed bibliographic record.
Preserves the original page's bibliographic link for the 1973 study; its scientific findings come from the publisher abstract.

Glossary

Tripeptide: A peptide composed of three amino-acid residues.
Coordination complex: A chemical association in which a metal ion binds to donor atoms on surrounding molecules.
Speciation: The distribution of different chemical forms of a substance in a particular environment.
Albumin: A major blood protein that transports and binds many small molecules, including metal ions.
Fibroblast: A cell that produces and remodels extracellular matrix.
Gene-expression signature: A pattern of gene activity associated with a condition or experimental response.